Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

NCT00625768 is registered in ClinicalTrials.gov with Antisoma Research as lead sponsor.

NCT NCT00625768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00625768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
Lead sponsor
Antisoma Research
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2009
Enrollment
13 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant melanoma, metastatic renal cell carcinoma